ArticleNucleic acids research2026
CMDdemux: an efficient single cell demultiplexing method.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Multiplexing technologies label cells with molecular tags, allowing cells from different donors to be pooled together for sequencing. Although this approach enhances cell throughput, eliminates batch effects, and enables doublet detection, limitations of hashtag-based labelling can still lead to low-quality data. Existing demultiplexing methods can accurately assign donor identities in high-quality datasets, but they often fail on low-quality data. To address this, we developed CMDdemux, a method comprising three key steps: within-cell centred log-ratio (CLR) normalization of hashtag count data, K-medoids clustering, and classification of cells based on Mahalanobis distance. By integrating both hashing and messenger RNA data, CMDdemux achieves high accuracy in distinguishing singlets, doublets, and negatives. It also provides visualization tools to help users inspect potentially misclassified droplets. We benchmarked CMDdemux against existing methods using a range of high- and low-quality datasets. Results show that CMDdemux consistently outperforms other approaches, demonstrating robust performance on both high- and low-quality data where other methods fail. CMDdemux is particularly effective in handling diverse types of low-quality multiplexing data across different multiplexing technologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.